secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDICINOVA INC (MNOV)
CIK:        0001226616
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001193125-26-060232
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MediciNova FY2025 net loss per share $0.24, operating loss $13.3M, cash down to $30.8M
--------------------------------------------------------------------------------

- Net loss attributable to shareholders $12.0M ($0.24 per share) vs $11.0M ($0.23) in FY2024.
- Operating loss widened to $13.3M from $12.7M; net sales (collaboration revenue) totaled $0.41M.
- Cash and equivalents fell to $30.8M from $40.4M; shareholders' equity decreased to $41.6M.
- No dividend paid; FY2026 guidance withheld due to uncertainty around out-licensing activities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1226616/000119312526060232/0001193125-26-060232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1226616/000119312526060232/d101814d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-060232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer